[Guidelines of the Spanish Society of Cardiology for cardiovascular disease prevention and cardiac rehabilitation] (Q74219044)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

title

[Guidelines of the Spanish Society of Cardiology for cardiovascular disease prevention and cardiac rehabilitation] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

cardiovascular disease

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

author name string

J A Velasco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

J Cosín

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

J M Maroto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

J A Casasnovas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

I Plaza

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

L T Abadal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

Revista Española de Cardiología

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

1095-1120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990-1992. REGICOR Investigators

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Serum cholesterol in young men and subsequent cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Correlation of serum lipids with the presence or absence of coronary artery disease in 1,793 men and women aged > or = 62 years

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

[Control of cholesterolemia in Spain, 2000. A tool for cardiovascular prevention]

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators.

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

The human costs of tobacco use (1)

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

The human costs of tobacco use (2)

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Coronary heart disease: epidemiology of smoking and intervention studies of smoking

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Passive smoking and coronary heart disease: a brief review

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Smoking and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

The acute influence of smoking on the endothelium

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

The primary prevention of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Smoking as a risk factor for recurrence of sudden cardiac arrest

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990.

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

The effect of treatment on mortality in "mild" hypertension: results of the hypertension detection and follow-up program

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

The association of changes in physical-activity level and other lifestyle characteristics with mortality among men

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

A meta-analysis of physical activity in the prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

An overview of randomized trials of rehabilitation with exercise after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Insulin Resistance Implications for Type II Diabetes Mellitus and Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Type A behavior, hostility, and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Chronic infections and coronary heart disease: is there a link?

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Dietary pattern and 20 year mortality in elderly men in Finland, Italy, and the Netherlands: longitudinal cohort study

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Diet and overall survival in elderly people

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

The Helsinki Heart Study: an 8.5-year safety and mortality follow-up

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Psychophysical bases of perceived exertion

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Randomized comparative trial of triflusal and aspirin following acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Timolol Treatment After Myocardial Infarction in Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

Secondary prevention of myocardial infarction in Spain. The PREVERSE study

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(00)75211-0

7 January 2021

10.1016/S0300-8932(00)75211-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10956605 AND SRC:MED&resulttype=core&format=json

9 November 2019

1 reference